Cytiva HiTrap™ MabSelect™ Prepacked Columns

Description

Prepacked HiTrap columns for process development, screening of purification conditions, and small-scale purification of Mabs. MabSelect media are suited for the high flowrates and pressures required when scaling up.

• Oriented coupling of recombinant Protein A ligand to the agarose matrix via an engineered C-terminal cysteine increases IgG binding capacity over other protein A media
• High capacity, low ligand leakage, and high-flow base matrix allow purification of Mabs at process scale
• Fewer regulatory concerns due to the total absence of mammalian culture in the ligand production and purification
• Designed for use with a syringe, a peristaltic pump, or a chromatography system

MabSelect

• Allows at least five times higher flowrates than conventional cross-linked agarose of similar porosity
• Recombinant Protein A ligand promotes specificity of binding to F_c region of IgG; permits one-step purification

• Same recombinant protein A ligand as MabSelect, but with a smaller particle size and greater porosity, for increased dynamic binding capacity
• Allows binding from samples with high expression levels of the monoclonal antibody
• Lowers overall production cost due to the possibility of processing concentrated feedstocks in fewer batches

• Akali-tolerant protein A-derived ligand allows the use of up to 0.5M NaOH for cleaning-in-place (CIP)
• Permits significant cost savings and extension of cycles in regular production